6 commercial payer policies list 67221. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
6 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 67221 |
|---|---|---|
| Age-Related Macular Degeneration | Feb 20, 2024 | Covered |
| Verteporfin (Visudyne) Photodynamic Therapy | Jun 29, 2023 | Covered |
| Policy | Effective | Status of 67221 |
|---|---|---|
| Photodynamic Therapy for Choroidal Neovascularization | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 67221 |
|---|---|---|
| Photodynamic Therapy for Choroidal Neovascularization | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 67221 |
|---|---|---|
| Photodynamic Therapy for Choroidal Neovascularization | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 67221 |
|---|---|---|
| Photodynamic Therapy for Choroidal Neovascularization | Dec 15, 2025 | Covered |